These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 16584400)
1. Multidrug resistance associated protein 2 mediates transport of prostaglandin E2. de Waart DR; Paulusma CC; Kunne C; Oude Elferink RP Liver Int; 2006 Apr; 26(3):362-8. PubMed ID: 16584400 [TBL] [Abstract][Full Text] [Related]
2. Hepatic transport of PKI166, an epidermal growth factor receptor kinase inhibitor of the pyrrolo-pyrimidine class, and its main metabolite, ACU154. Takada T; Weiss HM; Kretz O; Gross G; Sugiyama Y Drug Metab Dispos; 2004 Nov; 32(11):1272-8. PubMed ID: 15280219 [TBL] [Abstract][Full Text] [Related]
3. Involvement of multidrug resistance-associated protein 4 in efflux transport of prostaglandin E(2) across mouse blood-brain barrier and its inhibition by intravenous administration of cephalosporins. Akanuma S; Hosoya K; Ito S; Tachikawa M; Terasaki T; Ohtsuki S J Pharmacol Exp Ther; 2010 Jun; 333(3):912-9. PubMed ID: 20194529 [TBL] [Abstract][Full Text] [Related]
5. Adenosine triphosphate-dependent transport of anionic conjugates by the rabbit multidrug resistance-associated protein Mrp2 expressed in insect cells. van Aubel RA; van Kuijck MA; Koenderink JB; Deen PM; van Os CH; Russel FG Mol Pharmacol; 1998 Jun; 53(6):1062-7. PubMed ID: 9614209 [TBL] [Abstract][Full Text] [Related]
6. Involvement of Mrp2 (Abcc2) in biliary excretion of moxifloxacin and its metabolites in the isolated perfused rat liver. Ahmed S; Vo NT; Thalhammer T; Thalhammer F; Gattringer KB; Jäger W J Pharm Pharmacol; 2008 Jan; 60(1):55-62. PubMed ID: 18088505 [TBL] [Abstract][Full Text] [Related]
7. Prevention of Mrp2 activity impairment in ethinylestradiol-induced cholestasis by ursodeoxycholate in the rat. Crocenzi FA; D'Andrea V; Catania VA; Luquita MG; Pellegrino JM; Ochoa JE; Mottino AD; Sánchez Pozzi EJ Drug Metab Dispos; 2005 Jul; 33(7):888-91. PubMed ID: 15843489 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of impaired biliary excretion of acetaminophen glucuronide after acute phenobarbital treatment or phenobarbital pretreatment. Xiong H; Suzuki H; Sugiyama Y; Meier PJ; Pollack GM; Brouwer KL Drug Metab Dispos; 2002 Sep; 30(9):962-9. PubMed ID: 12167560 [TBL] [Abstract][Full Text] [Related]
9. Kupffer cell-derived prostaglandin E2 is involved in regulation of lipid synthesis in rat liver tissue. Neyrinck AM; Margagliotti S; Gomez C; Delzenne NM Cell Biochem Funct; 2004; 22(5):327-32. PubMed ID: 15338473 [TBL] [Abstract][Full Text] [Related]
10. Effect of acetaminophen on expression and activity of rat liver multidrug resistance-associated protein 2 and P-glycoprotein. Ghanem CI; Gómez PC; Arana MC; Perassolo M; Ruiz ML; Villanueva SS; Ochoa EJ; Catania VA; Bengochea LA; Mottino AD Biochem Pharmacol; 2004 Aug; 68(4):791-8. PubMed ID: 15276087 [TBL] [Abstract][Full Text] [Related]
11. Biliary excretion of flavopiridol and its glucuronides in the isolated perfused rat liver: role of multidrug resistance protein 2 (Mrp2). Jäger W; Gehring E; Hagenauer B; Aust S; Senderowicz A; Thalhammer T Life Sci; 2003 Oct; 73(22):2841-54. PubMed ID: 14511769 [TBL] [Abstract][Full Text] [Related]
12. Metabolism and disposition of resveratrol in the isolated perfused rat liver: role of Mrp2 in the biliary excretion of glucuronides. Maier-Salamon A; Hagenauer B; Reznicek G; Szekeres T; Thalhammer T; Jäger W J Pharm Sci; 2008 Apr; 97(4):1615-28. PubMed ID: 17724663 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of biliary excretion of methotrexate by probenecid in rats: quantitative prediction of interaction from in vitro data. Ueda K; Kato Y; Komatsu K; Sugiyama Y J Pharmacol Exp Ther; 2001 Jun; 297(3):1036-43. PubMed ID: 11356926 [TBL] [Abstract][Full Text] [Related]
14. Shift from biliary to urinary elimination of acetaminophen-glucuronide in acetaminophen-pretreated rats. Ghanem CI; Ruiz ML; Villanueva SS; Luquita MG; Catania VA; Jones B; Bengochea LA; Vore M; Mottino AD J Pharmacol Exp Ther; 2005 Dec; 315(3):987-95. PubMed ID: 16109740 [TBL] [Abstract][Full Text] [Related]
15. Identification of regions required for apical membrane localization of human multidrug resistance protein 2. Bandler PE; Westlake CJ; Grant CE; Cole SP; Deeley RG Mol Pharmacol; 2008 Jul; 74(1):9-19. PubMed ID: 18381564 [TBL] [Abstract][Full Text] [Related]
16. Involvement of Mrp2 in hepatic and intestinal disposition of dinitrophenyl-S-glutathione in partially hepatectomized rats. Villanueva SS; Ruiz ML; Luquita MG; Sánchez Pozzi EJ; Catania VA; Mottino AD Toxicol Sci; 2005 Mar; 84(1):4-11. PubMed ID: 15590889 [TBL] [Abstract][Full Text] [Related]
17. Multidrug resistance-associated protein 2 is primarily responsible for the biliary excretion of fexofenadine in mice. Tian X; Zamek-Gliszczynski MJ; Li J; Bridges AS; Nezasa K; Patel NJ; Raub TJ; Brouwer KL Drug Metab Dispos; 2008 Jan; 36(1):61-4. PubMed ID: 17913796 [TBL] [Abstract][Full Text] [Related]
18. Identification of interspecies difference in efflux transporters of hepatocytes from dog, rat, monkey and human. Li M; Yuan H; Li N; Song G; Zheng Y; Baratta M; Hua F; Thurston A; Wang J; Lai Y Eur J Pharm Sci; 2008 Sep; 35(1-2):114-26. PubMed ID: 18639632 [TBL] [Abstract][Full Text] [Related]
19. Multidrug resistance protein 2 is an important determinant of paclitaxel pharmacokinetics. Lagas JS; Vlaming ML; van Tellingen O; Wagenaar E; Jansen RS; Rosing H; Beijnen JH; Schinkel AH Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6125-32. PubMed ID: 17062689 [TBL] [Abstract][Full Text] [Related]
20. Interaction of valproic acid and carbapenem antibiotics with multidrug resistance-associated proteins in rat erythrocyte membranes. Ogawa K; Yumoto R; Hamada N; Nagai J; Takano M Epilepsy Res; 2006 Sep; 71(1):76-87. PubMed ID: 16806827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]